Curatis Holding Ltd header image

Curatis Holding Ltd

CURN

Equity

ISIN CH1330780979 / Valor 133078097

SIX Swiss Exchange (2026-07-30)
CHF 21.40%

Curatis Holding Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Curatis Holding Ltd is a Swiss-based pharmaceutical company specializing in the acquisition, licensing, distribution, and promotion of medicines for the treatment and prevention of orphan and specialty diseases. The company holds exclusive distribution rights for over 30 different drugs within Switzerland, many of which target rare and specialized medical conditions. Curatis is actively working to expand its market presence by securing distribution rights in major European markets, including Germany, France, the UK, and Italy. In the medium to long term, the company plans to launch its own products pending regulatory approval. Curatis' growth strategy is bolstered by its aim to increase visibility and funding opportunities through potential public listing. The executive management team, including CFO Patrick Ramsauer, brings extensive experience in finance and corporate governance, further supporting the company's strategic objectives.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

90.2%1Y
%3Y
%5Y

Performance

72.5%1Y
97.1%3Y
97.1%5Y

Volatility

Market cap

79 M

Market cap (USD)

Daily traded volume (Shares)

1,663

Daily traded volume (Shares)

1 day high/low

13.5 / 13

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.66%USD 73.03
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.24%USD 168.52
Rainbow Childrens Medicare Limited
Rainbow Childrens Medicare Limited Rainbow Childrens Medicare Limited Valor: 118549448
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%INR 1,516.00
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%EUR 27.30
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%INR 1,761.50
Teleflex Inc
Teleflex Inc Teleflex Inc Valor: 976212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.75%USD 132.30
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%USD 25.70
Bausch + Lomb Corporation
Bausch + Lomb Corporation Bausch + Lomb Corporation Valor: 116024614
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.88%USD 16.99
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-10.36%USD 37.11
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
27.29%USD 118.32